Immunoglobulins: Extending the Horizon
Seiten
1994
Taylor & Francis Ltd (Verlag)
978-1-85070-647-2 (ISBN)
Taylor & Francis Ltd (Verlag)
978-1-85070-647-2 (ISBN)
- Titel ist leider vergriffen;
keine Neuauflage - Artikel merken
The proceedings of the First Meeting of the European Haematology Association in Brussels in June 1994. It focuses on selected areas of IVIg therapy which relate to new and developing uses of IVIg, key issues for treatment and key areas of relevant clinical and basic investigation.
This is a high-level technical reference text on new and developing uses of intravenous immunoglobulin (IVIg), virological safety and other treatment issues, and active areas of relevant clinical and basic investigation. Volume editor Kazatchkine explains the importance of this work in his Foreword: IVIg therapy represents the first-line treatment in humoral immunodeficiencies. It also stands as an alternative or complementary approach to targeted immunointervention for immunomodulation of hypersensitivity states and autoimmune diseases. Thus, normal circulating immunoglobulins are now known to play an important role in the selection of immune repertoires and regulation of immune homeostasis, in addition to their role in host defense against infection.
This is a high-level technical reference text on new and developing uses of intravenous immunoglobulin (IVIg), virological safety and other treatment issues, and active areas of relevant clinical and basic investigation. Volume editor Kazatchkine explains the importance of this work in his Foreword: IVIg therapy represents the first-line treatment in humoral immunodeficiencies. It also stands as an alternative or complementary approach to targeted immunointervention for immunomodulation of hypersensitivity states and autoimmune diseases. Thus, normal circulating immunoglobulins are now known to play an important role in the selection of immune repertoires and regulation of immune homeostasis, in addition to their role in host defense against infection.
Mechanisms of action of intravenous immunoglobulin therapy in autoimmune and inflammatory disorders. B-chronic lymphocytic leukemia, hypogammaglobulinemia, and the use of intravenous polyvalent immunoglobulin. Intravenous immunoglobulin treatment of Guillain-Barre syndrome. Benefit of a 12 per cent solution of intravenous immunoglobulin in the treatment of steroid-dependent asthma. The safety of intravenous immunoglobulin: Sandoglobulin(R). Index.
| Erscheint lt. Verlag | 15.9.1994 |
|---|---|
| Verlagsort | London |
| Sprache | englisch |
| Gewicht | 299 g |
| Themenwelt | Medizinische Fachgebiete ► Innere Medizin ► Hämatologie |
| Studium ► Querschnittsbereiche ► Infektiologie / Immunologie | |
| ISBN-10 | 1-85070-647-6 / 1850706476 |
| ISBN-13 | 978-1-85070-647-2 / 9781850706472 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Hämatologie und Internistische Onkologie
Buch | Softcover (2023)
ecomed-Storck GmbH (Verlag)
CHF 179,95
Buch | Softcover (2024)
Urban & Fischer in Elsevier (Verlag)
CHF 73,00
Buch | Softcover (2023)
Deutscher Ärzteverlag
CHF 41,95
